Our 2018/2019 Ophthalmic Deals Book covers 108 ophthalmic company transactions in 2018 and 2019, including investments by venture capital firms, private equity, public stock offerings, and sales of companies. There are many new features in the 2019 version of this report, including a detailed analysis of each ophthalmic sector. This analysis reviews sector transaction counts and totals, sector allocation compared with other ophthalmic sectors, sector funds by use and type, and the top funded companies in each sector.
Also new in the 2019 version is an analysis of NIH and other grants to ophthalmology. A comprehensive list of retinal disease gene therapies in development and an additional 57 tables and figures are also new in 2019.
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.